Aug 2026· Advancement of science· 0 citations· 29 references
Medicine
TL;DR
It is demonstrated that CMA activity is downregulated in nucleus pulposus cells from IDD patients and IL‐1β‐induced rat intervertebral disc cell models, causing cytoplasmic accumulation of a novel CMA substrate, Midnolin (MIDN).
Abstract
ABSTRACT Intervertebral disc degeneration (IDD) is a leading cause of low back pain with incompletely understood mechanisms. Although autophagy dysfunction is a documented contributor to IDD, the precise pathobiological role of chaperone‐mediated autophagy (CMA) remains poorly understood. Here, we demonstrate that CMA activity is downregulated in nucleus pulposus cells (NPCs) from IDD patients and IL‐1β‐induced rat intervertebral disc cell models, causing cytoplasmic accumulation of a novel CMA substrate, Midnolin (MIDN). Accumulated MIDN bypasses the ubiquitin‐proteasome system and directly binds to Tuberous Sclerosis Complex 2 (TSC2), mediating its degradation. TSC2 loss relieves mechanistic target of rapamycin complex 1 (mTORC1) inhibition, resulting in mTORC1 hyperactivation, which drives cellular senescence, senescence‐associated secretory phenotype (SASP), and extracellular matrix (ECM) degradation in NPCs. In vitro and in a rat caudal needle puncture model, MIDN knockdown (shRNA), CMA activation (LAMP2A overexpression), or mTORC1 inhibition (Rapamycin) significantly attenuated IL‐1β or MIDN overexpression‐induced senescence and disc degeneration. Our findings reveal an “Impaired CMA–MIDN accumulation–TSC2 degradation–mTORC1 activation” axis central to IDD pathogenesis, offering potential therapeutic targets.
This study reveals the WTAP/ACSL4/IGF2BP2 axis as a mediator of IL‐1β‐induced LMP via m6A‐dependent lipid peroxidation, highlighting a potential therapeutic target for IVDD.
Shu Jia, Xu Gao, Lai-Min Zhu et al.· Advancement of science· 0 citations
Findings revealed the ETS1/DRP1 axis as a novel pathogenic mechanism and a potential therapeutic target in IVDD and inhibition of ETS1 via AAV5-mediated RNA interference or targeting DRP1 with CRISPR/dCas9-KRAB system or Mdivi-1 alleviated mitochondrial dysfunction, cellular senescence, ECM degradation, and attenuated...
Peng-Fei Li, Yi-Chen Que, Shuhao Zhang et al.· Cellular Signalling· 0 citations
This study clarifies the molecular mechanism by which the USP5/MATN3 axis regulates cellular senescence and affects IVDD progression, opening up new potential targets for the intervention strategy of IVDD.
Chunyang Fan, Jie-yun Xia, Yao Zhang et al.· Cellular Signalling· 0 citations
Both cellular and animal models confirm that intervention in the TRIM25/USP7/ENO1 axis effectively reverses metabolic imbalance and degenerative progression, offering a promising new therapeutic strategy for IDD.
Xiao-Ming Liu, Wen-Yu Zhang, Hang Feng et al.· Clinical and Translational M...· 0 citations
Collectively, rapa‐lipos target mTORC1‐mediated NCP and ALP to inhibit NP cell senescence, offering a promising strategy for intervertebral disc degeneration prevention.
Hui Xing, Miao Yu, Jia-Bin Liu et al.· Bioengineering & Translation...· 0 citations
It is demonstrated that youthful-state EVs (Y-EVs) outperform aged donor-derived EVs (O-EVs) in resolving inflammatory cascades within nucleus pulposus (NP) cells and establishes CD55 as a key determinant of their therapeutic superiority.
Zhi-Wei Liao, Kun Wang, M. Lei et al.· Biomedical Materials· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.